OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy of psychostimulant drugs for amphetamine abuse or dependence
Clara Pérez‐Mañá, Xavier Castells, Marta Torrens, et al.
Cochrane library (2013) Vol. 2013, Iss. 9
Closed Access | Times Cited: 87
Clara Pérez‐Mañá, Xavier Castells, Marta Torrens, et al.
Cochrane library (2013) Vol. 2013, Iss. 9
Closed Access | Times Cited: 87
Showing 1-25 of 87 citing articles:
Responding to global stimulant use: challenges and opportunities
Michael Farrell, Natasha K. Martin, Emily Stockings, et al.
The Lancet (2019) Vol. 394, Iss. 10209, pp. 1652-1667
Open Access | Times Cited: 249
Michael Farrell, Natasha K. Martin, Emily Stockings, et al.
The Lancet (2019) Vol. 394, Iss. 10209, pp. 1652-1667
Open Access | Times Cited: 249
Treatment of stimulant use disorder: A systematic review of reviews
Claire Ronsley, Seonaid Nolan, Rod Knight, et al.
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0234809-e0234809
Open Access | Times Cited: 152
Claire Ronsley, Seonaid Nolan, Rod Knight, et al.
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0234809-e0234809
Open Access | Times Cited: 152
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder
Frances R. Levin, John J. Mariani, Sheila Specker, et al.
JAMA Psychiatry (2015) Vol. 72, Iss. 6, pp. 593-593
Open Access | Times Cited: 153
Frances R. Levin, John J. Mariani, Sheila Specker, et al.
JAMA Psychiatry (2015) Vol. 72, Iss. 6, pp. 593-593
Open Access | Times Cited: 153
Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
Lídia Blanco-Silvente, Xavier Castells, Marc Sáez, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 20, Iss. 7, pp. 519-528
Open Access | Times Cited: 121
Lídia Blanco-Silvente, Xavier Castells, Marc Sáez, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 20, Iss. 7, pp. 519-528
Open Access | Times Cited: 121
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis
Vítor S. Tardelli, Adam Bisaga, Felipe B. Arcadepani, et al.
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2233-2255
Closed Access | Times Cited: 111
Vítor S. Tardelli, Adam Bisaga, Felipe B. Arcadepani, et al.
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2233-2255
Closed Access | Times Cited: 111
Non-pharmacological interventions for methamphetamine use disorder: a systematic review
P. V. Asharani, Aditi Hombali, Esmond Seow, et al.
Drug and Alcohol Dependence (2020) Vol. 212, pp. 108060-108060
Open Access | Times Cited: 101
P. V. Asharani, Aditi Hombali, Esmond Seow, et al.
Drug and Alcohol Dependence (2020) Vol. 212, pp. 108060-108060
Open Access | Times Cited: 101
Stimulant safe supply: a potential opportunity to respond to the overdose epidemic
Taylor Fleming, Allison Barker, Andrew Ivsins, et al.
Harm Reduction Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 70
Taylor Fleming, Allison Barker, Andrew Ivsins, et al.
Harm Reduction Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 70
Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients
Ruth Cunill, Xavier Castells, Aurelio Tobı́as, et al.
Psychopharmacology (2015) Vol. 233, Iss. 2, pp. 187-197
Closed Access | Times Cited: 77
Ruth Cunill, Xavier Castells, Aurelio Tobı́as, et al.
Psychopharmacology (2015) Vol. 233, Iss. 2, pp. 187-197
Closed Access | Times Cited: 77
Catechol-O-methyltransferase, dopamine, and sleep-wake regulation
Yves Dauvilliers, Mehdi Tafti, Hans‐Peter Landolt
Sleep Medicine Reviews (2014) Vol. 22, pp. 47-53
Closed Access | Times Cited: 76
Yves Dauvilliers, Mehdi Tafti, Hans‐Peter Landolt
Sleep Medicine Reviews (2014) Vol. 22, pp. 47-53
Closed Access | Times Cited: 76
Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine
Jaanus Harro
International review of neurobiology (2015), pp. 179-204
Closed Access | Times Cited: 74
Jaanus Harro
International review of neurobiology (2015), pp. 179-204
Closed Access | Times Cited: 74
Pharmacotherapy for amphetamine dependence: A systematic review
Nicole K. Lee, Linda Jenner, Angela Harney, et al.
Drug and Alcohol Dependence (2018) Vol. 191, pp. 309-337
Closed Access | Times Cited: 64
Nicole K. Lee, Linda Jenner, Angela Harney, et al.
Drug and Alcohol Dependence (2018) Vol. 191, pp. 309-337
Closed Access | Times Cited: 64
‘Resurgent’, ‘twin’ or ‘silent’ epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America
Benedikt Fischer, Caroline O’Keefe-Markman, Angelica Lee, et al.
Substance Abuse Treatment Prevention and Policy (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 44
Benedikt Fischer, Caroline O’Keefe-Markman, Angelica Lee, et al.
Substance Abuse Treatment Prevention and Policy (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 44
Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
Margherita Barbuti, Marco Maiello, Vincenza Spera, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3096-3096
Open Access | Times Cited: 21
Margherita Barbuti, Marco Maiello, Vincenza Spera, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3096-3096
Open Access | Times Cited: 21
Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits
Verónica Bisagno, Betina González, Francisco J. Urbano
Pharmacological Research (2016) Vol. 109, pp. 108-118
Open Access | Times Cited: 55
Verónica Bisagno, Betina González, Francisco J. Urbano
Pharmacological Research (2016) Vol. 109, pp. 108-118
Open Access | Times Cited: 55
Interventions to address substance use and sexual risk among gay, bisexual and other men who have sex with men who use methamphetamine: A systematic review
Rod Knight, Mohammad Karamouzian, Anna Carson, et al.
Drug and Alcohol Dependence (2018) Vol. 194, pp. 410-429
Closed Access | Times Cited: 53
Rod Knight, Mohammad Karamouzian, Anna Carson, et al.
Drug and Alcohol Dependence (2018) Vol. 194, pp. 410-429
Closed Access | Times Cited: 53
Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis
Meha Bhatt, Laura Zielinski, Lola Baker-Beal, et al.
Systematic Reviews (2016) Vol. 5, Iss. 1
Open Access | Times Cited: 47
Meha Bhatt, Laura Zielinski, Lola Baker-Beal, et al.
Systematic Reviews (2016) Vol. 5, Iss. 1
Open Access | Times Cited: 47
The future of the international drug control system and national drug prohibitions
Wayne Hall
Addiction (2017) Vol. 113, Iss. 7, pp. 1210-1223
Closed Access | Times Cited: 46
Wayne Hall
Addiction (2017) Vol. 113, Iss. 7, pp. 1210-1223
Closed Access | Times Cited: 46
Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial
Farzin Rezaei, Maryam Emami, Shakiba Zahed, et al.
DARU Journal of Pharmaceutical Sciences (2015) Vol. 23, Iss. 1
Open Access | Times Cited: 44
Farzin Rezaei, Maryam Emami, Shakiba Zahed, et al.
DARU Journal of Pharmaceutical Sciences (2015) Vol. 23, Iss. 1
Open Access | Times Cited: 44
Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients
Lídia Blanco-Silvente, Dolors Capellà, Josep Garre‐Olmo, et al.
BMC Geriatrics (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 41
Lídia Blanco-Silvente, Dolors Capellà, Josep Garre‐Olmo, et al.
BMC Geriatrics (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 41
Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials
Heidar Sharafi, Hamzah Bakouni, Christina McAnulty, et al.
Addiction (2023) Vol. 119, Iss. 2, pp. 211-224
Open Access | Times Cited: 12
Heidar Sharafi, Hamzah Bakouni, Christina McAnulty, et al.
Addiction (2023) Vol. 119, Iss. 2, pp. 211-224
Open Access | Times Cited: 12
Psychostimulants
Andrew C. McCreary, Christian P. Müller, Małgorzata Filip
International review of neurobiology (2015), pp. 41-83
Closed Access | Times Cited: 39
Andrew C. McCreary, Christian P. Müller, Małgorzata Filip
International review of neurobiology (2015), pp. 41-83
Closed Access | Times Cited: 39
Modafinil Treatment of Cocaine Dependence: A Systematic Review and Meta-Analysis
Dinesh Sangroula, Fatima Motiwala, Bivek Wagle, et al.
Substance Use & Misuse (2017) Vol. 52, Iss. 10, pp. 1292-1306
Closed Access | Times Cited: 32
Dinesh Sangroula, Fatima Motiwala, Bivek Wagle, et al.
Substance Use & Misuse (2017) Vol. 52, Iss. 10, pp. 1292-1306
Closed Access | Times Cited: 32
Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders
Charlotte Skoglund, Lena Brandt, Brian M. D’Onofrio, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 11, pp. 1144-1152
Closed Access | Times Cited: 29
Charlotte Skoglund, Lena Brandt, Brian M. D’Onofrio, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 11, pp. 1144-1152
Closed Access | Times Cited: 29
Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
Heather Palis, Scott Macdonald
Canadian Medical Association Journal (2023) Vol. 195, Iss. 27, pp. E934-E935
Open Access | Times Cited: 8
Heather Palis, Scott Macdonald
Canadian Medical Association Journal (2023) Vol. 195, Iss. 27, pp. E934-E935
Open Access | Times Cited: 8
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials
Hamzah Bakouni, Heidar Sharafi, Arash Bahremand, et al.
Drug and Alcohol Dependence (2023) Vol. 253, pp. 111018-111018
Closed Access | Times Cited: 8
Hamzah Bakouni, Heidar Sharafi, Arash Bahremand, et al.
Drug and Alcohol Dependence (2023) Vol. 253, pp. 111018-111018
Closed Access | Times Cited: 8
